ATSN-201

· Atsena Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATSN-201, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis [Phase 1, Phase 2]